JP2022524151A5 - - Google Patents
Info
- Publication number
- JP2022524151A5 JP2022524151A5 JP2021553777A JP2021553777A JP2022524151A5 JP 2022524151 A5 JP2022524151 A5 JP 2022524151A5 JP 2021553777 A JP2021553777 A JP 2021553777A JP 2021553777 A JP2021553777 A JP 2021553777A JP 2022524151 A5 JP2022524151 A5 JP 2022524151A5
- Authority
- JP
- Japan
- Prior art keywords
- optionally substituted
- alkyl
- heterocycloalkyl
- cycloalkyl
- heteroaryl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024203544A JP2025037920A (ja) | 2019-03-14 | 2024-11-21 | 環状ペプチド抗生物質 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNPCT/CN2019/078189 | 2019-03-14 | ||
| CN2019078189 | 2019-03-14 | ||
| PCT/US2020/022272 WO2020185999A1 (en) | 2019-03-14 | 2020-03-12 | Cyclic peptide antibiotics |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024203544A Division JP2025037920A (ja) | 2019-03-14 | 2024-11-21 | 環状ペプチド抗生物質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022524151A JP2022524151A (ja) | 2022-04-27 |
| JP2022524151A5 true JP2022524151A5 (enExample) | 2023-03-22 |
| JP7670618B2 JP7670618B2 (ja) | 2025-04-30 |
Family
ID=70190176
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021553777A Active JP7670618B2 (ja) | 2019-03-14 | 2020-03-12 | 環状ペプチド抗生物質 |
| JP2024203544A Pending JP2025037920A (ja) | 2019-03-14 | 2024-11-21 | 環状ペプチド抗生物質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024203544A Pending JP2025037920A (ja) | 2019-03-14 | 2024-11-21 | 環状ペプチド抗生物質 |
Country Status (5)
| Country | Link |
|---|---|
| US (1) | US12358951B2 (enExample) |
| EP (1) | EP3938377A1 (enExample) |
| JP (2) | JP7670618B2 (enExample) |
| CN (1) | CN113710687A (enExample) |
| WO (1) | WO2020185999A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP7670618B2 (ja) * | 2019-03-14 | 2025-04-30 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | 環状ペプチド抗生物質 |
| WO2022009212A1 (en) * | 2020-07-09 | 2022-01-13 | Technion Research And Development Foundation Ltd. | TYROSINE, TRYPTOPHAN AND PHENYLALANINE AS mTOR AGONISTS MEDIATING PROTEASOME DYNAMICS, COMPOSITIONS, METHODS AND USES THEREOF IN THERAPY, AND PROGNOSTIC METHODS FOR DRUG-RESISTANCE |
| CN118307583A (zh) * | 2024-04-03 | 2024-07-09 | 上海科技大学 | β氨基酯、聚β氨基酯化合物及其制备方法及应用 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS594990B2 (ja) | 1977-05-13 | 1984-02-02 | 三共株式会社 | 抗生物質グロボマイシン |
| JPS5547644A (en) | 1978-10-02 | 1980-04-04 | Meiji Seika Kaisha Ltd | New antibiotics sf-1902 a2, a3, a4 and a5 and their preparation |
| US5384309A (en) | 1989-07-17 | 1995-01-24 | Genentech, Inc. | Cyclized peptides and their use as platelet aggregation inhibitors |
| US10787490B2 (en) | 2015-07-15 | 2020-09-29 | Protaganist Therapeutics, Inc. | Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases |
| EP3377471A4 (en) * | 2015-11-11 | 2019-11-20 | Encycle Therapeutics, Inc. | FRAGMENT SYNTHESIS OF CYCLIC PEPTIDES |
| EP3681875B1 (en) * | 2017-09-15 | 2026-01-14 | F. Hoffmann-La Roche AG | Cyclic peptide antibiotics |
| JP7670618B2 (ja) * | 2019-03-14 | 2025-04-30 | エフ・ホフマン－ラ・ロシュ・アクチェンゲゼルシャフト | 環状ペプチド抗生物質 |
-
2020
- 2020-03-12 JP JP2021553777A patent/JP7670618B2/ja active Active
- 2020-03-12 CN CN202080027001.9A patent/CN113710687A/zh active Pending
- 2020-03-12 WO PCT/US2020/022272 patent/WO2020185999A1/en not_active Ceased
- 2020-03-12 EP EP20717453.3A patent/EP3938377A1/en active Pending
-
2021
- 2021-09-10 US US17/447,361 patent/US12358951B2/en active Active
-
2024
- 2024-11-21 JP JP2024203544A patent/JP2025037920A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2013104951A (ru) | Циклические бороновые кислотно-эфирные производные и их использование в терапии | |
| JP2023159197A5 (enExample) | ||
| JP2021522167A5 (enExample) | ||
| JP2022137011A5 (enExample) | ||
| RU2016146581A (ru) | Макроциклические антибиотики широкого спектра действия | |
| JP2019527196A5 (enExample) | ||
| FI3986419T3 (fi) | Boorihappojohdannaisia ja niiden terapeuttisia käyttöjä | |
| CA2504448A1 (en) | Transcription factor modulating compounds and methods of use thereof | |
| JP2023518418A5 (enExample) | ||
| RU2016107436A (ru) | Линейные пептидные антибиотики | |
| RU2018122505A (ru) | Макроциклические антибиотики широкого спектра действия | |
| JP2017517567A5 (enExample) | ||
| JP2016501864A5 (enExample) | ||
| JP2016528257A5 (enExample) | ||
| JP2020507564A5 (enExample) | ||
| RU2686740C2 (ru) | Ингибиторы бета-лактамазы | |
| SI2344129T1 (en) | AEROSOL FLUOROKINOLONAL FORMULATIONS FOR IMPROVED PHARMACOKINETICS | |
| RU2018122498A (ru) | Макроциклические антибиотики широкого спектра действия | |
| EP3139930B1 (en) | Salts and polymorphs of cyclic boronic acid ester derivatives and therapeutic uses thereof | |
| JP2020510044A5 (enExample) | ||
| RU2012111458A (ru) | Применение левофлоксацина в форме аэрозоля для лечения муковисцидоза | |
| WO2011101710A1 (en) | Efflux pump inhibitors | |
| EP3849562B1 (en) | Combination compositions comprising a beta-lactamase inhibitor | |
| HRP20161230T2 (hr) | Aerosolizirani fluorokinoloni i njihova uporaba | |
| JP7819925B2 (ja) | ボロン酸誘導体およびその治療的使用 |